Skip to main content
Premium Trial:

Request an Annual Quote

Singular Genomics Systems: David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, Daniel Shoemaker

Singular Genomics Systems has formed a scientific advisory board comprising David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, and Daniel Shoemaker.

Barker, also a member of the firm's board of directors, is a former Illumina chief scientific officer. He is also board chair at Bionano Genomics. He holds a doctorate in biochemistry from Brandeis University.

Fong is a professor of cancer biology at the University of California, San Francisco and codirector of the Parker Institute of Cancer Immunotherapy. He holds an MD from Stanford University.

Ledbetter is chief clinical and research officer at Unified Patient Network. He holds a doctorate from the University of Texas-Austin.

Mardis, also a board member, is coexecutive director of the Institute of Genomic Medicine at Nationwide Children's Hospital. A former president of the American Association for Cancer Research, she holds a doctorate in chemistry and biochemistry from the University of Oklahoma.

Shoemaker is formerly CSO at Fate Therapeutics. He holds a doctorate in biochemistry from Stanford.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.